Join
Live feed
·
INSIDERFilingvia Quantisnow
Agile Therapeutics Inc. logo

Director Hubbard John W returned $1,484 worth of shares to the company (976 units at $1.52), closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AGRX· Agile Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGRX (Agile Therapeutics Inc.) and more on Quantisnow.